Ph.D., Professor, head of chair of General surgery Kursk state medical University
профессор, д.м.н., заведующий кафедрой общей хирургии Курского государственного медицинского университета
Head of the Department of X-ray Surgical Diagnostic and Treatment Methods
к.м.н., заведующий отделением рентгенохирургических методов диагностики и лечения
cardiovascular surgeon of the department of X-ray surgical diagnostics and treatment
сердечно-сосудистый хирург отделения рентгенохирургических методов диагностики и лечения
head physician
главный врач
Ph.D., Associate Professor, Department of General Surgery
к.м.н., доцент кафедры общей хирургии
doctor of the department of X-ray surgical methods of diagnosis and treatment
врач отделения рентгенохирургических методов диагностики и лечения
The aim of the study was to improve the conservative treatment options for proximal deep vein thrombosis of low extremities associated with phlegmasia alba dolens optimization of anticoagulant therapy and paravascular injection of the anti-inflammatory medical mixture in areas of the most intense inflammatory process.Materials and methods. The results of treatment of two statistically homogeneous groups of patients with proximal deep vein thrombosis of the lower extremities associated with white phlegmasia were compared. In the first group (n = 30), standard conservative treatment was carried out using rivaroxaban as an anticoagulant; in the second group (n = 30), initial heparin therapy was first performed and, additionally, the following mixture was administered in the places of the greatest severity of inflammatory process under ultrasound control: dexamethasone 16 mg, heparin 5 thousand units, 0.25% novocaine solution 20.0 ml. During treatment the incidence of hemorrhagic syndrome was recorded. The results were assessed after one year according to the degree of deep vein lumen restoration and the severity of venous outflow impairment according to the Villalta scale. Results. In patients of both groups, every tenth patient developed some minor manifestations of hemorrhagic syndrome during treatment with rivaroxaban that was corrected by a decrease in the dose of anticoagulant.Complete restoration of the lumen of the veins occurred in 20.0%, patients of the first group and in 40.0%, patients of the second group; partial, in 63.3% and 56.7% of patients, respectively, minimal - in 16.7% and 3.3% of patients, respectively.In the first group, clinical disorders of venous outflow were absent in 20.0% of patients, a weak degree of severity was registered in 23.3%, an average - in 40.0%, and a strong one in 16.7% of patients, and in the second group, in 40 %, 26.7%, 30% and 3.3% of patients, respectively.Different minor hemorrhagic complications after Rivaroxaban intake occurred equally in both groups in each of ten patients. These complications were treated by the reduction of the anticoagulant’s dose.Complete restoration of the vein lumen occurred in the first group in 20.0%, and in the second group in 40.0% of patients, partial restoration, in 63.3% and 56.7% of patients, minimal - in 16.7% and 3.3% of patients respectively.In patients of the first group clinical venous congestion was absent in 20,0% of patients, mild congestion was manifested in 23,3% of patients, moderate - in 40,0% of patients, and severe was in 16,7% of cases. In the second group, the obtained data was 40%, 26,7%, 30%, and 3,3% of patients, respectively. Conclusion. Starting therapy with heparin and paravascular injection of anti-inflammatory mixture helps improve treatment outcomes.
Полное восстановление просвета вен произошло в первой группе у 20,0%, а во второй группе у 40,0%, частичное соответственно – у 63,3% и 56,7%, минимальное – у 16,7% и 3,3%больных.
В первой группе клинические нарушения венозного оттока отсутствовали у 20,0% , слабая степень выраженности зарегистрирована у 23,3%, средняя - у 40,0%, а сильная – у 16,7%,а во второй группе соответственно у40%,у26,7%,у30% и у 3,3% пациентов